Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines
- Document Type
- Publications · Journal Article
- Registered DB
- KCISCIEScopus
- Journal Ranking
- JCR Q3Scopus Q2
- Journal
- Annals of Laboratory Medicine37(2) · pp.180 · 2017
- Citation
- Web of Science 15KCI 4
- JCR IF
- JCR 2016 2.174
- ISSN
- 2234-3806
Authors
- 김솔잎First author인제대학교부속일산백병원
- 윤여민건국대학교
- 채효진가톨릭대학교
- 조현정건양대학교
- 지미숙중앙보훈병원 진단검사의학과
- Kim, In Suk부산대학교
- 이경아연세대학교
- 이우창울산대학교
- 송상훈서울대학교
- 우혜인성균관대학교
- 이수연Corresponding author성균관대학교
- 전사일Corresponding author울산대학교
Abstract
Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.
Keywords
Clinical laboratoryKoreaPharmacogeneticsTestingPractice guidelineIMPLEMENTATION CONSORTIUM GUIDELINESMETASTATIC COLORECTAL-CANCERTHIOPURINE METHYLTRANSFERASE GENOTYPEWARFARIN DOSE REQUIREMENTSDRUG-METABOLIZING-ENZYMESOF-AMERICAN-PATHOLOGISTSBREAST-CANCERGENETIC POLYMORPHISMSKOREAN POPULATIONCYP2C19 GE
Identifiers
- WoS UID
- 000391776500017
- KCI
- ART002204107



Login
Back to Publication list